AGEN2373 is the first CD137 agonist antibody reporting single agent responses with no major toxicity
Responses reported in patients with prostate cancer, ampullary carcinoma and metastatic vulvar. | June 5, 2023
Agenus (AGEN) Presents Positive Efficacy and Safety Outcomes for AGEN2373 streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
– Data Across 30 Abstracts Reinforce Leadership in Metastatic Breast Cancer and Demonstrate Breadth of Pipeline Across Lung, Hematologic, Genitourinary, Gastrointestinal, Gynecological and. | May 17, 2023